Innotherapy Stock Last Dividend Paid
246960 Stock | KRW 8,370 340.00 3.90% |
InnoTherapy fundamentals help investors to digest information that contributes to InnoTherapy's financial success or failures. It also enables traders to predict the movement of InnoTherapy Stock. The fundamental analysis module provides a way to measure InnoTherapy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InnoTherapy stock.
InnoTherapy |
InnoTherapy Company Last Dividend Paid Analysis
InnoTherapy's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, InnoTherapy has a Last Dividend Paid of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Pharmaceuticals (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
All Next | Launch Module |
InnoTherapy Fundamentals
Return On Equity | -66.34 | |||
Return On Asset | -0.13 | |||
Operating Margin | (6.16) % | |||
Current Valuation | 84.92 B | |||
Shares Outstanding | 5.04 M | |||
Shares Owned By Insiders | 28.30 % | |||
Shares Owned By Institutions | 0.20 % | |||
Price To Sales | 97.27 X | |||
Revenue | 507.29 M | |||
Gross Profit | 339.33 M | |||
EBITDA | (3.23 B) | |||
Net Income | (5.04 B) | |||
Cash And Equivalents | 1.03 B | |||
Cash Per Share | 375.11 X | |||
Total Debt | 17.17 B | |||
Debt To Equity | 0.56 % | |||
Current Ratio | 6.75 X | |||
Cash Flow From Operations | (3.98 B) | |||
Number Of Employees | 26 | |||
Beta | 1.49 | |||
Market Capitalization | 44.19 B | |||
Total Asset | 31.88 B | |||
Z Score | 1.2 | |||
Net Asset | 31.88 B |
About InnoTherapy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InnoTherapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InnoTherapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InnoTherapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with InnoTherapy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InnoTherapy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InnoTherapy will appreciate offsetting losses from the drop in the long position's value.Moving together with InnoTherapy Stock
0.74 | 102940 | Kolon Life Science | PairCorr |
0.63 | 074430 | Aminologics CoLtd | PairCorr |
0.81 | 047920 | HLB Pharmaceutical | PairCorr |
Moving against InnoTherapy Stock
The ability to find closely correlated positions to InnoTherapy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InnoTherapy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InnoTherapy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InnoTherapy to buy it.
The correlation of InnoTherapy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InnoTherapy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InnoTherapy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InnoTherapy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in InnoTherapy Stock
InnoTherapy financial ratios help investors to determine whether InnoTherapy Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InnoTherapy with respect to the benefits of owning InnoTherapy security.